News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BIND Biosciences, Inc. to Present at UBS Global Life Sciences Conference



9/10/2012 9:32:30 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Biosciences, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called AccurinsTM, announced today that Scott Minick, BIND’s CEO, is scheduled to present at the UBS Global Life Sciences Conference at 10:00 a.m. ET on Thursday, September 20, 2012, at the Grand Hyatt, New York.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES